Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia

Clinical Pediatrics

Volumn 35, Issue 12, 1996, Pages 629-633

  Amir, Jacob ^a   Harel, Liora ^b   Eidlitz Markus, Tal ^b   Varsano, Itzhak ^b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFIXIME; CEFTRIAXONE;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL;

EID: 0030443310     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289603501204     Document Type: Article

References (15)

1. Guatkur DR. How many die? A set of demographic estimates of the annual number of infants and child deaths in the world. Am J Public Health. 1980; 70:1286-1289.
2. Dagan R, Syogiannopoulos G, Ashkenazi S, et al. Parenteral-oral switch in the management of paediatric pneumonia. Drugs. 1991;47:43-51.
3. Vogel F and Multicenter Trial Group. Efficacy and tolerance of cefotaxime followed by oral cefixime vs cefotaxime in patients with lower respiratory tract infection. 18th International Congress of Chemotherapy, Stockholm, Sweden, Abstract # 5044, June 27-July 2, 1993.
4. Neijens V, Bergman J, Lowe S, et al. Oral cefibacten therapy after a short course of ceftriaxone treatment in patients with severe infections. 18th International Congress of Chemotherapy, Stockholm, Sweden, Abstract #6, 1993, p. 514.
5. Drewelow B, Maass AB, Koch K. Penetration of cefuroxime into bronchial secretions during sequential therapy with cefuroxime-exetil. 18th International Congress of Chemotherapy, Stockholm, Sweden, Abstract #7, 1993, p. 379.
6. Ramires J, Sprinath L, Akee S, Raff N. Switch therapy with oral cefixime after intravenous third-generation cepholosporin for the treatment of community-acquired pneumonia. 18th International Congress of Chemotherapy, Stockholm, Sweden, Abstract #1375, 1993, p. 42.
7. Stille W, Kranz-Jansen M, Maass AB, Vogel F. Sequential therapy of community-acquired pneumonia: Intravenous cefuroxime versus intravenous cefuroxime followed by cefuroximeexetil in the treatment of primary pneumonia. 18th International Congress of Chemotherapy, Stockholm, Sweden, Abstract #1376, 1993, p 43.
8. Gooch WM, Congen BL, Swenson BS, Snellman LW. Effectiveness and safely of augmentin in the management of pneumonia by infants and children. Curr Ther Res. 1985;37:178-183.
9. Neu HC, Wilson APR, Gruneberg RN. Amoxicillin/clavulanic acid: A review of ils efficacy in over 38,500 patients from 1979-1992. J Chemother. 1993; 15:67-93.
10. Barry AL, Jones RN. Cefixime: Spectrum of antibacterial activity against 16,016 clinical isolates. Pediatr Infect Dis J. 1987;6:954-957.
11. Neu HC. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime. Pediatr Infect Dis J. 1987;6:958-962.
12. Leibowitz E, Tabachnick E, Fliedel O, et al. Once daily intrainuscular ceftriaxone in the outpatient treatment of severe community acquired pneumonia in children. Clin Pediatr. 1990; 29:634-659.
13. Dagan R, Phillips M, Watenberg N, Kassis I. Outpatients treatment of serious community-acquired pediatric infection using once daily intramuscular ceftriaxone. Pediatr Infect Dis J. 1987;6: 1080-1084.
14. Kiani R, Johnson D, Nelson B. Comparative multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections. Am J Med. 1988;85:6-13.
15. Norden CW. Osteomyelitis. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles of Practice of Infections Diseases, 3rd ed. New York: Churchill Livingston, Inc; 1990:922-930.